endovascular.es

Título: Medtronic to open new facility in Galway, Ireland to manufacture IN.PAC Admiral drug-coated balloon
Fecha: 14-12-2015
Medtronic announced Monday a new facility in Galway, Ireland that will manufacture the company's IN.PAC Admiral drug-coated balloon (DCB) for the treatment of peripheral artery disease. Tony Semedo, president of Medtronic's Aortic & Peripheral Vascular business, remarked "our global market leadership in DCB is driving the need to open the new facility." He added that "once fully operational, this facility will be the only DCB manufacturing area of its kind in Medtronic worldwide."
According to Medtronic, around 100 employees from other parts of the company's organisation will be stationed in the new facility. The 20 000 square feet facility will cost around 13 million euros ($14.3 million), the device maker added.
In January, the IN.PAC Admiral DCB gained FDA approval for the treatment of peripheral artery disease in the upper leg, and waslaunched the following month. Medtronic noted at the time that the acquisition of Covidien was allowing the company to significantly expand its peripheral vascular sales force to get this product to market faster.
Fuente: endovascular.es

endovasculares.es